The International Restless Legs Syndrome Study Group (IRLSSG) is an organization whose members are "professionals committed to advancing basic and clinical research on RLS"
Their members include RLS experts from around the world including all the ones we know.
However on their website under Treatment they list 2 studies. One is on iron and is fine. The other is an outdated 2013 article that reviewed studies on RLS medicines.
It recommended levodopa, rotigotine gabapentin enacarbil and pregabalin. It did not recommend gabapentin, tramadol, methadone or any other opioids nor intravenous use of ferric carboxymaltose or iron sucrose.
It did mention augmentation, however it summarized by saying "Either dopamine-receptor agonists or the a2d ligands are the first-line treatment"
This is even though at their 2024 Annual Meeting they had experts we all know speaking and they discussed the new AASM guidelines.
I wrote to the secretary pointing this out and suggesting they delete that article and add the Mayo Algorithm and the ASSM guidelines and asked her to pass it on to the Executive Director. It will probably be ignored